Cargando…
Developing New Agents for Treatment of Childhood Cancer: Challenges and Opportunities for Preclinical Testing
Developing new therapeutics for the treatment of childhood cancer has challenges not usually associated with adult malignancies. Firstly, childhood cancer is rare, with approximately 12,500 new diagnoses annually in the U.S. in children 18 years or younger. With current multimodality treatments, the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038510/ https://www.ncbi.nlm.nih.gov/pubmed/33916592 http://dx.doi.org/10.3390/jcm10071504 |